|
Under the direction of Drs. Steven Treon (Dana Farber Cancer Institute, Boston, MA), Meletios Dimopoulos (University of Athens, Athens Greece), and Robert Kyle (Mayo Clinic, Rochester MN), the Second International Workshop on Waldenstrom’s Macroglobulinemia met in Athens, Greece. The highlight of this conference at which 55 investigators including 6 Young Investigator Award Recipients, representing 32 Medical Centers and 9 nations, were the deliberations of four consensus panels which generated comprehensive guidelines for the diagnosis, treatment and management of Waldenstrom’s macroglobulinemia. Dr. Treon served as the organizing chair for the four consensus panels which empanelled experts on Waldenstrom’s macroglobulinemia from around the world.
The conference was made possible through unrestricted grants or gifts provided by Amgen, Inc., Berlex Oncology, Inc., the Peter and Helen Bing Fund at the Dana Farber cancer Institute, Celgene Corp, Genentech BioOncology Inc., IDEC Pharmaceuticals Inc., the International Waldenstrom’s Macroglobulinemia Foundation, the Paul Mattis Family, the Research Fund for Waldenstrom’s Macroglobulinemia at the Dana Farber Cancer Institute, and the Research Fund for Waldenstrom’s Macroglobulinemia.
Please
visit our
sponsors and partner
organizations.
|
